After an extraordinarily challenging year for global health, the past few months have produced a flood of predictions for 2026. If one stepped back and curated them all, what trends would actually rise to the top? We were curious and curated 40 articles and reports from trusted media, policy institutions, multilaterals, industry voices, and research organizations to identify the common threads shaping the year ahead. While not exhaustive, this synthesis offers key trends reshaping global health systems, innovation ecosystems, and markets — especially in LMICs where need, innovation, and opportunity intersect. Here’s what we found.

1. Aid contraction is structural, not cyclical. Multiple analyses describe the decline in traditional donor growth as a long-term transition rather than a temporary downturn. Domestic resource mobilization, co-financing, and blended finance are accelerating, while development finance institutions (DFIs), private capital, and philanthropy are reshaping funding flows. Health actors face rising pressure to demonstrate measurable impact, efficiency, and financial sustainability in a constrained environment.
2. U.S. global health policy has shifted from multilateral aid to bilateral, security- and investment-framed engagement. The America First Global Health Strategy aligns health investments with U.S. national security, economic competitiveness, and measurable ROI — prioritizing bilateral compacts over pooled, multilateral mechanisms. USAID’s restructuring and the rise of state-led agreements signal a move away from traditional grant-based programming toward deal-based diplomacy and development finance tools.
3. Country ownership is rising and reshaping power dynamics. Governments — particularly in LMICs — are asserting stronger control over priorities, procurement systems, data governance, and regulatory pathways. Alignment with national strategies is increasingly a prerequisite for engagement. Bilateral, transactional agreements — especially between the U.S. and African countries — are redefining engagement models and shifting the balance of influence between national governments and global actors.
4. AI and digital transformation are accelerating — but governance of data and models will determine outcomes. AI and digital infrastructure are increasingly framed as efficiency multipliers in fiscally constrained systems — particularly for workforce support, surveillance, and system optimization. However, rapid, largely unregulated scaling of AI introduces significant risks around bias, privacy, accountability, and inequitable use. In 2026, regulatory oversight, liability frameworks, interoperability standards, and health data governance are moving to center stage, with global forums such as the World Health Assembly positioned to advance ethical standards for data access, use, and stewardship that enable responsible AI deployment. Countries are asserting stronger control over model deployment and data rights (“sovereign AI”), while cross-border frameworks are being discussed to balance innovation with safety and equity.
5. AI could widen inequities — or enable leapfrogging in LMICs — depending on infrastructure access and market concentration. Without inclusive datasets, reliable connectivity, and foundational digital infrastructure, AI risks excluding billions in low-resource settings. Yet some leaders argue LMICs may leapfrog legacy systems if tools are context-driven, embedded in primary care, and aligned with community health worker workflows. At the same time, the growing concentration of compute power and cloud infrastructure among a small number of global technology firms raises new geopolitical and equity concerns. Infrastructure access — not just regulatory readiness — may determine whether AI expands opportunity or entrenches disparities in 2026 and beyond. (see our AI series for additional insights and case studies)
6. Geopolitics is reshaping multilateral cooperation and global health architecture. WHO financing reform, Pandemic Agreement implementation, and broader UN restructuring are unfolding amid sovereignty tensions, funding uncertainty, and the rise of bilateral, interest-driven agreements. Questions about future support for the WHO, the Global Fund, and pooled procurement mechanisms are intensifying as health diplomacy becomes intertwined with trade and industrial policy. In 2026, multilateral platforms will be tested on their ability to sustain global public goods — including surveillance, R&D coordination, and outbreak response — in a more transactional, multipolar environment.
7. Climate change is no longer peripheral — it is foundational to health planning. Extreme heat, vector-borne disease, food insecurity, displacement, and climate-linked instability are increasingly embedded in national health strategies. Health systems must now plan for chronic environmental stress rather than episodic emergencies, particularly in climate-vulnerable LMICs. Furthermore, as AI infrastructure expands rapidly into water-stressed and marginalized communities, the foreseeable linkages between local water depletion, reduced sanitation, and preventable illness — particularly among children — demand urgent attention.
8. Health is increasingly framed in economic terms — and projects must prove ROI. Immunization, preparedness, and primary care are positioned not only as humanitarian imperatives but as drivers of labor productivity, macroeconomic stability, and national resilience. In a tighter fiscal climate, the economic case for health investment is becoming central. As grant-heavy models decline, initiatives seeking private capital must demonstrate clearer revenue pathways and risk-mitigation strategies. There are rising concerns that “bankable” deals may crowd out primary care and workforce investments that lack near-term revenue streams.
9. U.S. science funding volatility is creating downstream risk for global R&D and innovation ecosystems. Fiscal pressures and congressional scrutiny affecting NIH and other research-related agencies are creating uncertainty for university–industry partnerships, clinical trial networks, and biomedical innovation pipelines. For pharma, biotech, tech firms, academic institutions — and LMIC research collaborations dependent on U.S.-funded science — predictability in federal investment is increasingly consequential for long-term innovation and international collaboration.
10. Development finance institutions are becoming central actors in global health. With aid budgets tightening, DFIs and multilateral development banks are expanding through loans, guarantees, and equity investments aligned with national security and industrial policy goals. The reauthorized U.S. Development Finance Corporation (DFC), with expanded capital authority and equity tools, is positioned to finance health security infrastructure, vaccine manufacturing, and digital platforms — contingent on commercial viability, foreign policy alignment, and measurable impact thresholds. (See our DFC deep dive)
11. Philanthropy’s influence is growing — but remains concentrated and selective. A small number of mega-foundations dominate development philanthropy, with health continuing to receive a significant share. Philanthropic capital is increasingly agenda-setting — particularly in innovation and digital health — while facing growing scrutiny around equity, transparency, and measurable impact.
12. Financing models for AI in health remain unresolved. Sustainable capital for AI-enabled health systems — particularly in LMICs — remains experimental. Donors, philanthropies, DFIs, and private firms are testing blended approaches, but AI initiatives increasingly must demonstrate scalability, system integration, and alignment with national economic strategies to attract catalytic investment.
13. Success in LMIC markets requires investment in the full health system — not just new products. At the 2026 J.P. Morgan Healthcare Conference, industry leaders emphasized that succeeding in Asia and Africa requires investment across the full health ecosystem — regulatory alignment, financing pathways, supply chains, workforce readiness, and digital infrastructure — rather than investing solely in product launches. This systems lens mirrors broader AI and digital health trends, where impact depends on interoperable data, governance frameworks, and institutional capacity. (See our JPM 2026 convenings)
14. Implementation disruption and operational uncertainty are real — with projected mortality consequences. Frontline organizations report that rapid restructuring and funding shifts have created implementation gaps, supply chain delays, workforce disruptions, and planning uncertainty across LMIC health systems. Security-driven prioritization may deprioritize fragile settings lacking strategic value, raising equity concerns. An analysis in The Lancet projects that sustained funding cuts beginning in 2025 could result in between 9.4 and 22.6 million additional deaths by 2030, underscoring the potential scale of systemic disruption if current trajectories persist.

Sources

1. From Crisis to Resilience: Five Global Health Shifts to Watch in 2026 [Economist]
2. The Old Aid Model Is Dead; Now Comes the Fight Over What Replaces It [Devex]
3. Transforming the Global Health Ecosystem for a Healthier World in 2026 [ThinkGlobalHealth]
4. Seven Principles for Re-imagining Global Health, by Mike Reid,  MD, MPH, MA, Chief Science Officer, U.S. State Department Bureau of Global Health Security & Diplomacy and UCSF Faculty. [Stanford Presentation, January 26, 2026]
5. PSI: What PSI Is Looking Forward to in 2026
6. Deloitte: The 2026 Global Health Care Outlook
7. UN Foundation: Aligning Global Health Reforms in 2026
8. Understanding the health issues set to dominate 2026 [Euronews]
9. Brookings: What Should Be the Top Priorities for Africa in 2026? 
10. Gavi: The viruses experts are watching in 2026 
11. Gavi: Good health is the world’s best investment – and key to economic resilience
12. Key Moments for Climate and Health Diplomacy in 2026 [HealthPolicy]
13. Rising Climate Shocks Threaten Health in 2026 — Here’s How to Respond [Devex]
14. AI’s growing thirst for water is becoming a public health risk [Al Jazeera]
15. Vital Strategies:  Foundations & Futures: Reimagining Public Health in the Artificial Intelligence Era 
16. Audere: Predictions about AI in 2026 [ManagedHealthCare]
17. UC Berkeley: Eleven AI Trends to Watch in 2026 
18. Development Finance Trends to Watch in 2026 [Devex]
19. The challenges facing philanthropy in 2026 [Devex]
20. Stanford: What Davos Said About AI This Year 
21. Forces Reshaping Global Health in 2026 [ICT]
22. Let 2026 be the year the world comes together for AI safety [Nature]
23. BCG: How AI Agents and Tech Will Transform Health Care in 2026
24. WHO: WHO Director-General’s opening remarks at the 158th session of the Executive Board – 2 February 2026
25. Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis [Lancet]
26. MSF: How US Policies Are Reshaping Global Health and Humanitarian Aid One Year Later
27. America First Global Health Strategy [USG]
28. Questions for the America First Global Health Strategy [ThinkGlobalHealth]
29. The America First Global Health Strategy and Pooled Procurement [KFF]
30. The Danger of an “America First” Global Health Strategy [GlobalHealthNOW]
31. Inside Trump’s $11 Billion Health Plan to Replace “Neo-Colonial” USAID [Axios]
32. US–Africa bilateral health deals won’t help against diseases that ignore borders [Nature]
33. Harms of the Federal Funding Freeze on Science [BrennanCenter]
34. New Data on the World’s Biggest Development Philanthropies [Devex]
35. Financialization Won’t Improve Global Health [ProjectSynd]
36. What the Development Finance Corporation Reauthorization Means for Global Health Security [ThinkGlobalHealth]
37. Low-Resource Nations May Leapfrog Wealthier Ones in Using AI for Health [Devex]
38. Health AI: No Health Reform Without Better AI Governance [Devex]
39. AI in healthcare: risks could exclude 5 billion people — here’s what we can do about it [WEF]
40. America Needs Better AI Ambitions [TechPolicy]
41. Health Policy at a Crossroads: What to Watch in 2026 [HealthAffairs]
42. Transform Health: Opinion | Health Data Governance Is an Enabler for AI Ambitions [Devex]